NDC 63323-489-01 - XYLOCAINE-MPF WITH EPI
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-489
- Requested NDC
- 63323-489-01
- Package NDCs from labels
- 63323-489-02, 63323-489-27, 63323-489-03, 63323-489-21, 63323-489-01, 63323-489-17
- Manufacturer
- HF Acquisition Co LLC, DBA HealthFirst
- Effective date
- 2026-06-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| XYLOCAINE-MPF WITH EPI - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2026-06-19 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine - Henry Schein, Inc. | Henry Schein, Inc. | 2025-11-07 | HUMAN PRESCRIPTION DRUG LABEL |
| SODIUM CHLORIDE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-01-22 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine - General Injectables & Vaccines, Inc | General Injectables & Vaccines, Inc | 2022-12-22 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine MPF - Fresenius Kabi USA, LLC | Fresenius Kabi Austria | Fresenius Kabi USA, LLC | Fresenius Kabi Austria | 2021-08-25 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine MPF - A-S Medication Solutions | A-S Medication Solutions | 2019-09-25 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine MPF - Cardinal Health | Cardinal Health | 2019-09-09 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-489-01 | XylocaineMPF | 10 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 10 | 13 | |
| 63323-489-02 | XylocaineMPF | 20 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 20 | 13 | |
| 63323-489-03 | XylocaineMPF | 20 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 20 | 13 | |
| 63323-489-17 | XylocaineMPF | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 13 | |
| 63323-489-21 | XylocaineMPF | 5 in 1 CARTON | INJECTION, SOLUTION | 5 | 13 | |
| 63323-489-27 | XylocaineMPF | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 13 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-489 | XYLOCAINE MPF (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION XYLOCAINE (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION XYLOCAINE MPF (LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 13 | Current NDC, Legacy NDC, 6 package rows | 20210831_ba082c2f-64f4-419d-9c88-74f203316e17.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-489-01 | ML - Milliliter | 63323-489 | 402305d2-a2ba-4b33-9fa8-ab46fcf60153 | 1 | 2020-04-20 |
| 63323-489-02 | ML - Milliliter | 63323-489 | df03fb66-fedf-4500-b351-a5ca5cb881c6 | 1 | 2020-01-03 |
| 63323-489-03 | ML - Milliliter | 63323-489 | 82287f5e-6d70-4e4e-b6f9-b8aed85aea88 | 1 | 2020-04-20 |
| 63323-489-17 | ML - Milliliter | 63323-489 | 060d2a30-ef0f-4217-b6a1-2b9480814a95 | 1 | 2012-07-24 |
| 63323-489-21 | ML - Milliliter | 63323-489 | 54ff07e7-5f48-4ea2-a418-1a939aa466c1 | 1 | 2012-07-24 |
| 63323-489-27 | ML - Milliliter | 63323-489 | 166479a5-291e-4225-b22f-086cf1193f69 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Citanest Forte DENTAL | PRILOCAINE HCL AND EPINEPHRINE | Dentsply Pharmaceutical Inc. | 60c8710b-ae55-4fdf-e053-2991aa0adc75 | 2024-02-29 | Warnings, Adverse reactions | 30Q7KI53AK |
| EPST PLUS | CARDUUS MARIANUS, CISTUS CANADENSIS, DULCAMARA, GALIUM APARINE, MAGNESIA MURIATICA, NATRUM SULPHURICUM, VISCUM ALBUM, MURIATICUM ACIDUM, FOLLICULINUM, AQUA MARINA, AILANTHUS GLANDULOSUS, BARYTA MURIATICA, CADMIUM METALLICUM, CEANOTHUS AMERICANUS, COCCULUS INDICUS, IRIDIUM METALLICUM, THUJA OCCIDENTALIS, CINCHONA OFFICINALIS, CALCAREA CARBONICA, CROTALUS CASCAVELLA | Deseret Biologicals, Inc. | c2bb50a8-e4f9-4af4-aefc-53c9c3cfcc25 | 2024-02-27 | Warnings | 451W47IQ8X QTT17582CB |
| LIDOCAINE HCI AND EPINEPHRINE | LIDOCAINE HCI AND EPINEPHRINE | HF Acquisition Co LLC, DBA HealthFirst | 957506a5-1b09-0736-e053-2995a90a0b63 | 2024-02-26 | Warnings, Adverse reactions | 1010751 |
| LIDOCAINE HCl AND EPINEPHRINE | LIDOCAINE HCL AND EPINEPHRINE | HF Acquisition Co LLC, DBA HealthFirst | a098ab6c-143f-77a5-e053-2a95a90a3e0a | 2024-02-22 | Warnings, Adverse reactions | 1010759 |
| LIDOCAINE HCI AND EPINEPHRINE | LIDOCAINE HCI AND EPINEPHRINE | HF Acquisition Co LLC, DBA HealthFirst | a0997348-6274-060a-e053-2a95a90abea7 | 2024-02-22 | Warnings, Adverse reactions | NDA006488 1010759 30Q7KI53AK EC2CNF7XFP |
| LIDOCAINE HCI AND EPINEPHRINE | LIDOCAINE HCI AND EPINEPHRINE | HF Acquisition Co LLC, DBA HealthFirst | a09af094-7cfc-1d47-e053-2a95a90a6b69 | 2024-02-22 | Warnings, Adverse reactions | NDA006488 1010759 30Q7KI53AK EC2CNF7XFP |
| LIDOCAINE HCl | LIDOCAINE HCL | HF Acquisition Co LLC, DBA HealthFirst | c1735498-0721-687c-e053-2a95a90a47f4 | 2024-02-19 | Warnings, Adverse reactions | 1737562 |
| Vivacaine | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | Septodont, Inc. | b4c60d8e-e350-45b2-9d6b-5815eeb6c994 | 2024-02-16 | Warnings, Adverse reactions | 30Q7KI53AK |
| Bladder Relief | CAUSTICUM, NATRUM MURIATICUM, NUX VOMICA, PULSATILLA (VULGARIS), SEPIA, STAPHYSAGRIA, THUJA OCCIDENTALIS | The Magni Company | b09bf037-703f-4c22-8535-b33d586ebefa | 2024-02-08 | Warnings | 451W47IQ8X |
| Lidocaine Hemorrhoid | LIDOCAINE HCL, PHENYLEPHRINE HCL, WITCH HAZEL | Walgreens Co | 10a47899-f4a0-66e8-e063-6394a90a11dd | 2024-02-05 | Warnings | EC2CNF7XFP |
| Marcaine with Epinephrine | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE | Hospira, Inc. | 93cf0914-de08-4ec6-8f8c-d663243b9958 | 2024-02-02 | Boxed warning, Warnings, Adverse reactions | 30Q7KI53AK |
| Natrum Muriaticum | SODIUM CHLORIDE | SEVENE USA | 11008014-fff6-4d5a-8c5c-a20443d7cc23 | 2024-01-30 | Warnings | 451W47IQ8X |
| LIDOCAINE HCI | LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | 8c63be55-5de4-7f72-e053-2995a90a102e | 2024-01-30 | Warnings, Adverse reactions | 1737761 |
| BUPIVACAINE HCI AND EPINEPHRINE | BUPIVACAINE HCI AND EPINEPHRINE | HF Acquisition Co LLC, DBA HealthFirst | 99516811-56e2-9c8a-e053-2a95a90ac9cb | 2024-01-30 | Warnings, Adverse reactions | 30Q7KI53AK |
| SENSORCAINE(R) (BUPIVACAINE HCI AND EPINEPHRINE) | SENSORCAINE(R) (BUPIVACAINE HCI AND EPINEPHRINE) | HF Acquisition Co LLC, DBA HealthFirst | 946ce625-3647-5083-e053-2a95a90a1ebc | 2024-01-30 | Boxed warning, Warnings, Adverse reactions | 30Q7KI53AK |
| 1% LIDOCAINE HCI | 1% LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | 999dd95d-87fe-12c0-e053-2995a90aa9f7 | 2024-01-30 | Warnings, Adverse reactions | 1010033 |
| LIDOCAINE HCI | LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | 993bc59e-5e71-bd9e-e053-2a95a90af85c | 2024-01-28 | Warnings, Adverse reactions | 1737761 |
| 2% LIDOCAINE HCI | 2% LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | 78d8fb0a-bfae-6599-e053-2991aa0a2e03 | 2024-01-28 | Warnings, Adverse reactions | 1010671 |
| XYLOCAINE | XYLOCAINE | HF Acquisition Co LLC, DBA HealthFirst | e3b3b462-8f35-68b8-e053-2995a90a6403 | 2024-01-27 | Warnings, Adverse reactions | NDA006488 1010033 EC2CNF7XFP |
| LACTATED RINGERS | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | a14ca7d9-de30-a303-e053-2a95a90a5304 | 2024-01-27 | Warnings, Adverse reactions | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.